Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06611410 · ClinicalTrials.gov registry record · NA
1 Week Crossover Study Between Two Soft Contact Lenses
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT06611410: Completed NA study, sponsored by CooperVision.
NCT06611410 is a NA study that has completed, run by CooperVision. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06611410, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The objective of this investigation is to compare the visual clinical performance of two daily disposable soft contact lenses.
Primary Outcome
High contrast, binocular, distance visual acuity (logMAR) will be measured at 1-week visit.
Interventions
- DEVICE Test Lenses (stenfilcon A)
- DEVICE Control Lenses (omafilcon A)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-06-05 |
| Est. Completion | 2024-07-26 |
| Phase | NA |
What the finished NCT06611410 record still lists
NCT06611410 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Test Lenses (stenfilcon A) is the first listed.
NCT06611410 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06611410 about?
NCT06611410 is a clinical study titled "1 Week Crossover Study Between Two Soft Contact Lenses". The objective of this investigation is to compare the visual clinical performance of two daily disposable soft contact lenses.
What is the current status of trial NCT06611410?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2024-06-05. Estimated completion is 2024-07-26.
What interventions are being tested in trial NCT06611410?
The interventions under investigation include: Test Lenses (stenfilcon A) (DEVICE), Control Lenses (omafilcon A) (DEVICE).
Who is sponsoring clinical trial NCT06611410?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06611410's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI